Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference
Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Morgan Stanley 2016 Global Health Care Conference
on Tuesday, September 13, 2016, in New York. Giovanni Caforio, M.D., chief executive officer will make formal remarks about the company and answer questions
at 11:10 a.m. EDT.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the
start of the live webcast. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative
medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Tim Power, 609-252-7509
timothy.power@bms.com
Bill Szablewski, 609-252-5894
william.szablewski@bms.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160906006198/en/